About the Company:
Nidan Laboratories and Healthcare Ltd operates 30 diagnostic cum collection centres are operational under the brand name of “Nidan Healthcare” and offer radiology, neurology, cardiology, dental as well as pathology services.
Out of the 35 Centre’s, 16 centre’s are under the Franchisee model where 1 centre acts as a fully operated diagnostic centre and 15 centre’s act solely as standalone collection centres.
Company provides integrated diagnostics services to more than 1 million patients per year.
Company offers a comprehensive range of approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines.
Company’s diagnostic services are provided by a medical professional team consisting of 94 laboratory doctors, radiologists, physicians and 256 well-trained technical staff in our operational network.
Services provided by the Company:
Company’s test menu includes pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays and ultrasounds to advanced radiology tests including computerized tomography (“CT”) scans, magnetic resonance imaging (“MRI”) scans.
Expansion by the Company:
Company over the next 5 years, intends to set up more centres PAN India, either by acquiring brown field projects especially in Rajasthan, Punjab or by using “Hub and Spoke model” within the Metro cities of India.
Company proposes to expand its diagnostic and collection centres PAN Mumbai by entering into Joint Ventures with various Laboratories such as Metropolis Healthcare Limited, SRL Diagnostics, on the terms and conditions as agreed between the parties.
Diagnostic Centre’s and Operational Network.
Since incorporation, company’s diagnostic’s centre’s are located within the Northern District of Mumbai and Pune and Southern District of Pune.
As on this date, 30 diagnostic cum collection centres are operational under the brand name of “Nidan Healthcare” and offer radiology, neurology, cardiology, dental as well as pathology services.
Out of the 35 Centre’s, 16 centre’s are under the Franchisee model where 1 centre acts as a fully operated diagnostic centre and 15 centre’s act solely as standalone collection centres.
Management Team:
- Mr. Edwin Francis Dabre (Designation: Executive Director)
- Ms. Tejal Anil Jayakar (Designation: Executive Director and CFO)
Objectives of the Issue:
Fresh Issue: (Rs.50 cr)
- Repayment / pre-payment, in full or in part, of certain borrowings availed by our Company.
- Additional Working Capital.
- General Corporate Expenses.
Fund Utilization:
| Particulars | Amount |
|---|---|
| Repayment of Loans | 16 cr |
| Additional Working Capital | 26 cr |
| General Corporate Expenses | 4.4 cr |
| To meet the expenses of the Issue | 3.6 cr |
Financials of the Company:
| (in Crores) | FY 19 | FY 20 | FY 21 | 30th June 2021 |
|---|---|---|---|---|
| Revenue | 20.97 | 22.19 | 21.85 | 7.84 |
| Net Profit | 0.22 | 0.71 | 2.30 | 1.08 |
Valuation of Peer Group Companies:
| Company Name | Face Value | EPS | PE Ratio | RoNW | NAV |
|---|---|---|---|---|---|
| Nidan Laboratories and Healthcare | 10 | 2.32 | 53.88 | 0.17% | 13.46 |
| Metropolis Healthcare Ltd | 2 | 35.97 | 55.73 | 25.91% | 2807.00 |
| Dr Lal PathLabs Ltd | 10 | 35.33 | 82.18 | 23.42% | 3704.95 |
IPO Details:
| Details | Info |
|---|---|
| Issue Opens on | 28th October 2021 |
| Issue Closes on:. | 2nd November 2021 |
| Issue Price | Rs.125 |
| Face Value | Rs.10 |
| Minimum Lot | 1000 shares |
| Minimum Investment | Rs.1,25,000 |
| Issue Constitutes | 28.78% |
| Issue Size | Rs.50 cr |
| Market Cap | Rs.173.75 cr |
| Listing at | NSE SME |
| Equity Shares Offered (Fresh) | 40,00,000 |
| Equity Shares Prior to the issue | 99,00,000 |
| Equity Shares after the issue | 1,39,00,000 |
Also Read : List of Upcoming IPO’s in India.
Important Dates:
| Finalization of Basis of Allotment | on or Before 9th November 2021 |
| Initiation of Refunds | on or Before 10th November 2021 |
| Credit of Equity Shares: | on or Before 11th November 2021 |
| Listing Date: | on or Before 12th November 2021 |
IPO Valuation Parameters:
| Earnings Per Share (EPS) | Price To Earnings ratio (PE) | Return on Net Worth (RoNW) | Net Asset Value (NAV) |
|---|---|---|---|
| 2.32 | 53.88 | 0.17% | 13.46 |
| Check IPO Allotment Status: |
|---|
Bigshare: http://www.bigshareonline.com/IPO/AllotmentBSE IPO Website: https://www.bseindia.com/IPO/Allotment |
| Company Contact Info: |
|---|
| Nidan Laboratories and Healthcare Ltd Swapnshilpa, Behind Aarti Apartment, Vartak Road, Virar (West) – 401303, Palagar, Maharashtra, India; Tel. No.: +91 8975610000; Email: cs@nidanhealthcare.co.in; Website: www.nidanhealthcare.co.in |
| IPO Registrar Info: |
|---|
| Bigshare Services Private Limited Bharat Tin Works Building, 1st Floor, Opp. Vasant Oasis, Makwana Road, Marol, Andheri (East), Mumbai – 400059, Maharashtra, India. Tel. No.: +91 22 62638200 Fax No.: +91 22 62638299 E-mail: ipo@bigshareonline.com Website: www.bigshareonline.com |
| Lead Manager to the Issue: |
|---|
| FIRST OVERSEAS CAPITAL LIMITED 1-2 Bhupen Chambers, Ground Floor, Dalal Street, Mumbai-400 001 Tel. No.: +91 22 40509999. Investor Grievance Email: investorcomplaints@focl.in Website: www.focl.in |
